Navigation Links
Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder
Date:12/27/2010

FRAZER, Pa., Dec. 27, 2010 /PRNewswire/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced that the company received a second Complete Response Letter from the U.S. Food and Drug Administration (FDA) for the supplemental new drug application (sNDA) for NUVIGIL(R) (armodafinil) Tablets [C-IV] for the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel.  In its letter to the company, the FDA reiterated its previously stated concerns regarding the NUVIGIL sNDA.  

"Cephalon believes we met the agreed upon safety and efficacy endpoints in the NUVIGIL sNDA clinical study conducted under a Special Protocol Assessment. However, following several conversations with the agency, and given this second complete response letter, the company believes that further communications with the FDA will not result in an approval of this application," said Dr. Lesley Russell, Chief Medical Officer at Cephalon. "As a result, the company is no longer pursuing this indication."

About NUVIGIL NUVIGIL is indicated to improve wakefulness in patients with excessive sleepiness associated with treated obstructive sleep apnea (OSA), shift work disorder (SWD), or narcolepsy.  In patients with OSA, NUVIGIL is used along with airway treatments for this condition.  The NUVIGIL (armodafinil) label includes a bolded warning for serious or life-threatening rash, including Stevens-Johnson Syndrome, requiring hospitalization and discontinuation of treatment, that has been reported in adults in association with the use of modafinil and armodafinil and in children in association with the use of modafinil, a racemic mixture of S and R modafinil (the latter is armodafinil, the active ingredient in NUVIGIL).  NUVIGIL is not approved for use in pediatric patients for any indication. The most common adverse events in controlled c
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cephalon Appoints J. Kevin Buchi as Chief Executive Officer and Member of Cephalon Board of Directors
2. Cephalon to Webcast Investor Day
3. Cephalon Announces FDA Approval of Risk Evaluation and Mitigation Strategies for NUVIGIL and PROVIGIL
4. Cephalon Signs Investment Agreement to Fund ChemGenex Oncology Clinical Development Operations
5. Cephalon Exercises its Option to Acquire BioAssets Development Corporation
6. Cephalon Announces FDA Approval of a Risk Evaluation and Mitigation Strategy for GABITRIL
7. Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predictive Biomerk Tumorgraft™ Platform
8. Celator® Pharmaceuticals Expands Research Agreement With Cephalon, Inc.
9. Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position
10. Cephalon Provides Update on Regulatory Review of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
11. Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... BURLINGAME, Calif. , July 30, 2015 /PRNewswire/ ... Patent and Trademark Office has granted the company ... property covering Cleave,s lead molecule CB-5083. ... quinazolines as inhibitors of p97," U.S. 9,062,026, allows ... CB-5083, a first-in-class, highly selective oral inhibitor of ...
(Date:7/30/2015)... , July 30, 2015  Alimera Sciences, Inc. (NASDAQ: ... in the research, development and commercialization of prescription ophthalmic ... quarter fiscal year 2015 financial results after the market ... call will follow on the same day at 4:30 ... President and Chief Executive Officer, and Rick Eiswirth ...
(Date:7/30/2015)...   HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the ... revenue of $73.6 million for the quarter ended ... the quarter ended June 30, 2014.  Currency fluctuations ... nine percentage points, during the three months ended ...
Breaking Medicine Technology:Alimera Sciences To Release Second Quarter Fiscal Year 2015 Financial Results 2HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 2HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 3HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 4HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 5HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 6HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 7HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 8HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 9HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 10HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 11HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 12HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 13HeartWare International Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 14
... , , NEW YORK, ... customizable webcasting and streaming media solutions and services, will ... Midwest Chapter Event: September Education Program to a virtual ... presentation by Disney Destinations for the leading organization of ...
... , , , Timing is ... , ROSEMONT, Ill., Sept. 1 Trauma patients who sustain ... they arrive at the emergency department. A review article published in ... Academy of Orthopaedic Surgeons (JAAOS) explains that trauma patients who ...
Cached Medicine Technology:Stream57 to Webcast PCMA Midwest Chapter Meeting Live on Sept. 30th 2Trauma 411: Prolonged Surgery Should be Avoided in Certain Cases 2Trauma 411: Prolonged Surgery Should be Avoided in Certain Cases 3
(Date:7/30/2015)... FL (PRWEB) , ... July 30, 2015 , ... ... software, TikiLIVE, has worked to protect victims in San Diego, California’s Gaslamp Quarter ... used by Gaslamp Quarter Plaza actively monitor the area for any suspicious ...
(Date:7/30/2015)... ... July 30, 2015 , ... " DevExpress ” was featured ... at small, medium, and large businesses making an impact in their industry. Susan ... and shared with viewers how DevExpress has provided software development tools that have ...
(Date:7/30/2015)... ... 30, 2015 , ... The Beryl Institute announces its sixth ... with Patient Experience Institute, these offerings reinforce the commitment to help frame and ... throughout the experience movement, and provide information and research to support expanded focus ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... today that the latest issue of Inclusive™ magazine, its multimedia publication focused on ... digital edition of the new issue, Volume 6, Issue 2, as well as ...
(Date:7/30/2015)... ... 2015 , ... Between 2012 and 2014 HIV infection rates rose from five ... June 17th. Those untreated heroin use disorders share their needles and spread the infection. ... throughout the community. Ultimately Florida’s HIV infection rates have bolstered to 23 percent due ...
Breaking Medicine News(10 mins):Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 2Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 3Health News:Software to Develop High-Performance Data-Driven Apps was Featured on NewsWatch Television 2Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 3Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 2Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 3Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 4Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 2Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 3
... the one-year,anniversary of the Smoke-free Illinois Act, prohibiting smoking ... completely smoke-free,apartment building, AMLI 900 is catering to those ... 900 S. Clark St. in the South Loop, this,luxury ... AMLI,s Breatheasy(TM) program strictly prohibits smoking ...
... N.J., Jan. 12 In conjunction with its fourth quarter 2008 earnings release ... (NYSE: CVD ) is pleased to invite you to listen to ... on Thursday, January 29, 2009 at 9:00 a.m. ET., What: ... Presentation, ...
... to do in a sagging economy? Not necessarily the quick ... the country,s leading plastic surgeons.Recently, the U.S. Food and Drug ... safety concerns regarding the use of dermal fillers. Although the ... the nasolabial fold (the creases running from the nose to ...
... healthcare providers, patients and their families may not understand ... DNR (do not resuscitate) ordersHARRISBURG, Pa., Jan. 12 ... Safety Authority in part show that healthcare providers, patients ... meanings and consequences of living wills and DNR (do ...
... Sam,s Club is hosting a,Pharmacy Challenge and Savings Checkup ... can check prices on their prescriptions and,over-the-counter medications against ... price on branded prescriptions. Membership is not,required to ... "Your Healthy Year" promotes a variety of ways ...
... researchers have used a new strategy to study inherited susceptibility for ... of genes that may play a key role in controlling this susceptibility. ... genes in human cancers. , ... (PRWEB) January 12, 2009 -- ...
Cached Medicine News:Health News:Chicago's First Smoke-Free Apartment Building Thriving in South Loop 2Health News:Dr. Sherrell Aston Addresses the Popularity of Dermal Fillers and Possible Long Term Side Effects 2Health News:Pennsylvania Patient Safety Authority Releases December Advisory 2Health News:Pennsylvania Patient Safety Authority Releases December Advisory 3Health News:Pennsylvania Patient Safety Authority Releases December Advisory 4Health News:Pennsylvania Patient Safety Authority Releases December Advisory 5Health News:Sam's Club(R) Hosts Pharmacy Challenge 2Health News:UCSF Researchers Use New Tools to Move in on Cancer Susceptibility Genes 2Health News:UCSF Researchers Use New Tools to Move in on Cancer Susceptibility Genes 3Health News:UCSF Researchers Use New Tools to Move in on Cancer Susceptibility Genes 4
... CELL-DYN 3200 sets a benchmark of ... scatter for WBC, RBC, PLT and ... the needs of today's laboratory. The ... differential analysis, automated sample handling, comprehensive ...
... Point-of-Care Data Networking is hospital bedside ... data networking. In seconds, point of ... transferred from nursing stations throughout the ... instantly available to laboratory staff and ...
... QuickVue In-Line Strep A Test allows for the ... from patient throat swab specimens. , ,QuickVue In-Line ... is the first strep A test waived under ... procedure allow testing to take place at the ...
... InstaCheck® Menopause Predictor Test is an in ... FSH in urine. Changes in FSH levels ... symptoms associated with stages of menopause. The ... obtain a visual, qualitative result and is ...
Medicine Products: